Protective Role of Ajmalicine Against Benzo(a)pyrene-induced Lung Cancer Through Regulation of Inflammatory and Oxidative Pathways
Pharmacognosy Magazine · 2026-12 · 22 (4) · 1508-1518
DOI: 10.1177/09731296261447607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacognosy Magazine, online erschienen am 11.06.2026. Verfasst von Hongqian Yan und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Lung cancer is a foremost global health challenge and remains the leading cause of cancer-related mortality worldwide. Despite advancements in early diagnosis and treatment, most cases are detected at advanced stages, which severely compromises survival rates. Current chemotherapeutic agents are often limited by toxicity and resistance, highlighting the urgent need for safer and more effective preventive strategies.
Objectives
The present study evaluated the chemopreventive potential of ajmalicine, an indole alkaloid, against benzo(a)pyrene (B(a)P)-induced lung carcinogenesis in rats. Materials and Methods Lung carcinogenesis was induced by oral administration of B(a)P for 4 consecutive weeks. Ajmalicine (20 mg/kg) was administered orally 1 week before and throughout the 16-week experimental period. Post-treatment, antioxidant status, xenobiotic detoxification enzymes, inflammatory cytokines, and caspase-3/9 activities were measured using standard commercial kits. Histopathological examination of lung tissues was performed to confirm the protective role of ajmalicine.
Results
Ajmalicine treatment significantly enhanced antioxidant markers while reducing xenobiotic detoxification enzyme activity in B(a)P-exposed rats. Furthermore, ajmalicine attenuated pro-inflammatory cytokines and increased caspase-3/9 activity, suggesting the induction of apoptosis. Histopathological findings corroborated its protective role by demonstrating improved lung tissue architecture.
Conclusion
These findings reveal, for the first time, that ajmalicine exhibits strong chemopreventive effects against B(a)P-induced lung carcinogenesis by modulating oxidative stress, inflammation, and apoptosis. Ajmalicine may represent a promising natural candidate for preventing carcinogen-induced lung cancer.
Zitieren
APA
Yan, H., Yu, X., Su, Y., Geng, L., & Pei, Y. (2026). Protective Role of Ajmalicine Against Benzo(a)pyrene-induced Lung Cancer Through Regulation of Inflammatory and Oxidative Pathways. Pharmacognosy Magazine, 22(4), 1508-1518. https://doi.org/10.1177/09731296261447607
Vancouver
Yan H, Yu X, Su Y, Geng L, Pei Y. Protective Role of Ajmalicine Against Benzo(a)pyrene-induced Lung Cancer Through Regulation of Inflammatory and Oxidative Pathways. Pharmacognosy Magazine. 2026;22(4):1508-1518. doi:10.1177/09731296261447607
BibTeX
@article{Yan2026,
author = {Yan, Hongqian and Yu, Xiangyan and Su, Yinghao and Geng, Limei and Pei, Yuzhen},
title = {Protective Role of Ajmalicine Against Benzo(a)pyrene-induced Lung Cancer Through Regulation of Inflammatory and Oxidative Pathways},
journal = {Pharmacognosy Magazine},
year = {2026},
volume = {22},
number = {4},
pages = {1508--1518},
doi = {10.1177/09731296261447607}
}
EUVIMED